Mesa Laboratories (MLAB) News Today $141.70 -4.20 (-2.88%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$141.55 -0.15 (-0.11%) As of 02/21/2025 04:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Calculating The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)February 21 at 7:47 PM | uk.finance.yahoo.comMesa Laboratories (NASDAQ:MLAB) Shares Cross Above 200-Day Moving Average - Time to Sell?Mesa Laboratories (NASDAQ:MLAB) Stock Price Passes Above Two Hundred Day Moving Average - Here's What HappenedFebruary 19 at 6:29 AM | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) Shares Bought by Rice Hall James & Associates LLCRice Hall James & Associates LLC raised its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 25.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 27,668 shares of the medical instruments suppFebruary 19 at 5:23 AM | marketbeat.comWhat Makes Mesa Laboratories (MLAB) a Valuable Stock?February 13, 2025 | insidermonkey.comMesa Laboratories (NASDAQ:MLAB) Reaches New 1-Year High - Here's What HappenedMesa Laboratories (NASDAQ:MLAB) Sets New 52-Week High - What's Next?February 11, 2025 | marketbeat.comWells Fargo Sticks to Their Sell Rating for Mesa Laboratories (MLAB)February 10, 2025 | markets.businessinsider.comAnalysts Conflicted on These Technology Names: Workday (WDAY) and Mesa Laboratories (MLAB)February 7, 2025 | markets.businessinsider.comKeyBanc maintains Mesa Labs stock Sector Weight ratingFebruary 5, 2025 | msn.comMesa Laboratories (NASDAQ:MLAB) Stock, Short Interest ReportFebruary 5, 2025 | benzinga.comMesa Laboratories (NASDAQ:MLAB) Sets New 1-Year High on Earnings BeatMesa Laboratories (NASDAQ:MLAB) Reaches New 1-Year High After Earnings BeatFebruary 5, 2025 | marketbeat.comRecap: Mesa Laboratories Q3 EarningsFebruary 4, 2025 | benzinga.comMesa Laboratories (NASDAQ:MLAB) Stock Price Up 12.3% Following Strong EarningsMesa Laboratories (NASDAQ:MLAB) Trading Up 12.3% After Earnings BeatFebruary 4, 2025 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Releases Earnings Results, Beats Estimates By $0.66 EPSMesa Laboratories (NASDAQ:MLAB - Get Free Report) posted its quarterly earnings data on Tuesday. The medical instruments supplier reported $2.07 EPS for the quarter, beating the consensus estimate of $1.41 by $0.66. Mesa Laboratories had a positive return on equity of 28.52% and a negative net margin of 107.56%.February 4, 2025 | marketbeat.comMesa Labs reports Q3 EPS (31c) vs. 39c last yearFebruary 4, 2025 | markets.businessinsider.comMesa Laboratories Non-GAAP EPS of $2.72 beats by $1.21, revenue of $62.84M beats by $4.01MFebruary 4, 2025 | seekingalpha.comMesa Labs Announces Third Quarter ResultsFebruary 4, 2025 | globenewswire.comConestoga Capital Advisors LLC Grows Stake in Mesa Laboratories, Inc. (NASDAQ:MLAB)Conestoga Capital Advisors LLC lifted its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 8.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 573,037 shares of the medical instruments supplFebruary 3, 2025 | marketbeat.comMesa Laboratories (MLAB) to Release Quarterly Earnings on MondayMesa Laboratories (NASDAQ:MLAB) will be releasing earnings before the market opens on Monday, February 3, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=657517)January 27, 2025 | marketbeat.comJPMorgan Chase & Co. Has $1.09 Million Stake in Mesa Laboratories, Inc. (NASDAQ:MLAB)JPMorgan Chase & Co. raised its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 29.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 8,406 shares of the medical instruments supplier's stock aftJanuary 25, 2025 | marketbeat.comMesa Labs stock soars to 52-week high of $149.5 amid robust growthJanuary 24, 2025 | msn.comMesa Laboratories (NASDAQ:MLAB) Stock Price Down 4.8% - What's Next?Mesa Laboratories (NASDAQ:MLAB) Trading Down 4.8% - What's Next?January 23, 2025 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Reaches New 52-Week High - Should You Buy?Mesa Laboratories (NASDAQ:MLAB) Reaches New 52-Week High - Here's What HappenedJanuary 21, 2025 | marketbeat.comMesa Laboratories, Inc. to Announce Third Quarter Results on February 4, 2025January 17, 2025 | globenewswire.comBarclays PLC Has $1.15 Million Stock Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)Barclays PLC raised its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 357.4% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 8,837 shares of the medical instruments supplier's stock after buying an addiJanuary 14, 2025 | marketbeat.comJane Street Group LLC Decreases Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)Jane Street Group LLC lowered its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 89.7% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,308 shares of the medical instruments suJanuary 10, 2025 | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) Plans Quarterly Dividend of $0.16Mesa Laboratories, Inc. (NASDAQ:MLAB) declared a quarterly dividend on Tuesday, January 7th. Stockholders of record on Friday, February 28th will be given a dividend of 0.16 per share by the medical instruments supplier on Monday, March 17th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.46%. The ex-dividend date is Friday, February 28th.January 7, 2025 | marketbeat.comMESA LABS DECLARES QUARTERLY DIVIDENDJanuary 6, 2025 | globenewswire.comMesa Laboratories (NASDAQ:MLAB) Sets New 1-Year High - What's Next?Mesa Laboratories (NASDAQ:MLAB) Hits New 1-Year High - Should You Buy?January 6, 2025 | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) Stock Position Lifted by Principal Financial Group Inc.Principal Financial Group Inc. boosted its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 21.8% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 35,107 shares of the medical insJanuary 3, 2025 | marketbeat.comGeode Capital Management LLC Acquires 5,771 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)Geode Capital Management LLC grew its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 4.8% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 124,761 shares of the medical instruments supplier's stock after acquiring an adDecember 30, 2024 | marketbeat.comBarclays PLC Purchases 6,905 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)Barclays PLC lifted its position in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 357.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,837 shares of the medical instruments supplier's stock after acquiring an additDecember 30, 2024 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Stock Price Down 3.1% - Here's What HappenedMesa Laboratories (NASDAQ:MLAB) Trading Down 3.1% - Here's What HappenedDecember 24, 2024 | marketbeat.comState Street Corp Raises Stock Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)State Street Corp increased its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 9.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 214,148 shares of the medical instruments supplier'sDecember 23, 2024 | marketbeat.comMeros Investment Management LP Has $4.32 Million Stock Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)Meros Investment Management LP grew its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 17.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 33,240 shares of the medical inDecember 11, 2024 | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) Stock Holdings Boosted by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. raised its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 38.6% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 62,609 shares of the medical instrumenDecember 11, 2024 | marketbeat.comJanus Henderson Group PLC Has $10.15 Million Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)Janus Henderson Group PLC lessened its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 31.4% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 78,194 shares of the medical instruments supplier's stock after sellinDecember 9, 2024 | marketbeat.comVictory Capital Management Inc. Acquires 6,643 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)Victory Capital Management Inc. boosted its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 90.3% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 14,001 shares of the medical instruments suppNovember 25, 2024 | marketbeat.comEagle Asset Management Inc. Raises Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)Eagle Asset Management Inc. boosted its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 10.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 165,955 shares of the medical instrumeNovember 23, 2024 | marketbeat.comSegall Bryant & Hamill LLC Has $2.66 Million Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)Segall Bryant & Hamill LLC decreased its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 23.8% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,470 shares of the medicalNovember 23, 2024 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Stock Price Up 9.3% - Here's What HappenedMesa Laboratories (NASDAQ:MLAB) Stock Price Up 9.3% - What's Next?November 22, 2024 | marketbeat.comPrincipal Financial Group Inc. Has $4.56 Million Stock Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)Principal Financial Group Inc. increased its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 21.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 35,107 shares of the medical instruments supplier's stock after pNovember 22, 2024 | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) Shares Sold by Royce & Associates LPRoyce & Associates LP reduced its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 12.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 347,145 shares of the medical instruments supplier's stoNovember 15, 2024 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Stock Rating Lowered by StockNews.comStockNews.com lowered shares of Mesa Laboratories from a "buy" rating to a "hold" rating in a research report on Wednesday.November 13, 2024 | marketbeat.comMesa Labs price target lowered to $150 from $160 at Evercore ISINovember 13, 2024 | markets.businessinsider.comMesa Laboratories Reports Robust Q2 FY25 ResultsNovember 9, 2024 | markets.businessinsider.comMesa Labs Announces Second Quarter ResultsNovember 7, 2024 | globenewswire.comStockNews.com Upgrades Mesa Laboratories (NASDAQ:MLAB) to "Buy"StockNews.com raised shares of Mesa Laboratories from a "hold" rating to a "buy" rating in a research note on Tuesday.November 5, 2024 | marketbeat.comRice Hall James & Associates LLC Has $2.87 Million Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)Rice Hall James & Associates LLC lifted its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 44.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 22,108 shares of the medical instrumentsNovember 2, 2024 | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) Shares Sold by Conestoga Capital Advisors LLCConestoga Capital Advisors LLC reduced its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 7.6% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 529,110 shares of the medical instruments suppliNovember 1, 2024 | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) CEO Gary M. Owens Sells 2,518 SharesOctober 30, 2024 | insidertrades.com Get Mesa Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for MLAB and its competitors with MarketBeat's FREE daily newsletter. Email Address MLAB Media Mentions By Week MLAB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MLAB News Sentiment▼1.170.60▲Average Medical News Sentiment MLAB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MLAB Articles This Week▼32▲MLAB Articles Average Week Get Mesa Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for MLAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DAKT News FARO News VPG News COHR News BMI News CGNX News ITRI News OSIS News SENS News HURC News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MLAB) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mesa Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mesa Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MLAB Stock Alerts